According to the report titled ‘GLOBAL Digital Genome Market 2021-2028’, available with Market Study Report, global digital genome market, valued at USD 10061.6 million in 2020, is anticipated to reach USD 20902.1 million by the year 2028, growing at 9.57% CAGR during 2021-2028.
 

Soaring occurrence of chronic diseases in recent years has burdened the healthcare system, which along with continuous monetary government support for the research & development in genomics is stimulating the growth of global digital genome market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3552197/
 

Moreover, technological advancements and rising awareness in the developing economies are expected to contribute to industry outlook. However, certain risks associated with digital genomes, coupled with lack of seasoned professionals are expected to create hinderance in the business scenario.
 

Based on product, worldwide digital genome market is divided as sequencing & analysis software, DNA/RNA analysis, sample prep instruments, sequencing & analyzer instruments, and sequencing chips. In terms of application, the market is classified as drug discovery, diagnostics, personalized medicine, academic research, agricultural, and others. The end user spectrum is segmented as academic research institutes, hospitals, diagnostic & forensic labs, and others.
 

Geographically, the report widely covers business dynamics and expansion prospects across Latin America, North America, Asia Pacific, Europe, and Middle East & Africa. Of these, North America holds substantial industry share presently and is expected to showcase similar growth trends over the forecast period.
 

The anticipated growth of North America digital genome market is attributed to rising cases of monogenic diseases, coupled with technical advancements in genomics. Moreover, presence of renowned research institutes in the U.S. with skilled professionals working rigorously on research & development is further boosting regional industry size.
 

The companies defining the competitive landscape of global digital genome market are Thermo Fisher Scientific Inc., Regeneron Pharmaceuticals Inc., Abbott Laboratories, bioMérieux SA, Oxford Nanopore Technologies Ltd., Pacific Bioscience of California Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Illumina Inc., Qiagen N.V., Inscripta Inc., PerkinElmer Inc., and Becton Dickinson & Company (BD).